By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Modigene 

8000 Towers Crescent Drive
Suite 1300
Vienna  Virginia  22182  U.S.A.
Phone: 703-448-7688 Fax: 703-288-0070


SEARCH JOBS








Company News
Modigene (MODG.OB) Shareholders Approve Company Name Change and Other Proposals at Annual Meeting 6/12/2009 8:41:41 AM
Modigene (MODG.OB) Sets Record Date for Annual Meeting of Shareholders 2/10/2009 11:51:58 AM
Modigene (MODG.OB) Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone 1/27/2009 8:03:30 AM
Modigene (MODG.OB) Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP 1/15/2009 8:56:02 AM
Modigene (MODG.OB) Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta 8/5/2008 11:01:55 AM
Modigene (MODG.OB) Platform Validated in Independent Phase III Trial of CTP Technology; Modigene Shares Jump 50% on Schering-Plough Corporation (SGP) Results 7/10/2008 10:33:56 AM
Modigene Announces Closing of $12 Million Financing by Members of The Frost Group 3/27/2008 7:28:57 AM
Modigene Announces Appointment of Dr. Phillip Frost as Chairman of Its Board of Directors 3/5/2008 8:12:46 AM
Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Human Growth Hormone 11/27/2007 7:49:35 AM
Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs 9/24/2007 11:15:47 AM
12
//-->